KRAS and adenocarcinoma: However, no significant association was observed between KRAS mutation and other clinicopathological features including tumor location, tumor size, stage, lymph node involvement, metastasis, adenocarcinoma and mucinous adenocarcinoma, neural invasion, vascular invasion and intraepithelial neoplasia nearby.